Beta Drugs Share Price
07 Aug, 2026 3:59 PM (IST)
Beta Drugs Performance
- Today's Low
- ₹2,306
- Today's High
- ₹2,600
- 52 Week Low
- ₹990
- 52 Week High
- ₹2,674
- Open Price₹2,540
- Previous Close₹2,519
- Volume99,552
- 50 DMA₹2,069.40
- 100 DMA₹1,843.60
- 200 DMA₹1,710.80
Beta Drugs Chart
Investment Returns
- Over 1 Month + 10.23%
- Over 3 Month + 75.56%
- Over 6 Month + 72.04%
- Over 1 Year + 37.19%
Smart Investing Starts Here Start SIP with Beta Drugs for Steady Growth!
Beta Drugs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 54
- PEG Ratio
- -
- Market Cap Cr
- 2,464
- P/B Ratio
- 10.1
- Average True Range
- 151.5
- EPS
- 43.9
- Dividend Yield
- 0
- MACD Signal
- 87.9
- RSI
- 56.82
- MFI
- 35.5
Latest Stock News Updates
The buying on the counter came after the company received the approval for listing its equity shares on the Capital Market Segment (Main Board) from SME Emerge platform (NSE)
- Business Standard
- 8 months 2 weeks ago
Bonus shares: Here are three stocks to trade ex-bonus next week ' These include Beta Drugs, Dhanalaxmi Roto Spinners, and KBC Global)
- livemint
- 1 year 4 months ago
The company will use the newly raised funds to accelerate its growth and aspires to be among the top five oncology companies in India.
- NDTV Profit
- 1 year 8 months ago
Beta Drugs Financials
Beta Drugs Technicals
EMA & SMA
- Bearish Moving Average 2
- Bullish Moving Average 14
- 20 Day
- ₹2,286.00
- 50 Day
- ₹2,069.40
- 100 Day
- ₹1,843.60
- 200 Day
- ₹1,710.80
Resistance and Support
- R3 2,841.10
- R2 2,720.60
- R1 2,547.10
- S1 2,253.10
- S2 2,132.60
- S3 1,959.10
Beta Drugs Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-07-20 | Quarterly Results | To consider and approve the financial results for the period ended Jun 30, 2026 |
| 2026-05-14 | Audited Results | |
| 2026-02-14 | Quarterly Results | |
| 2026-01-09 | Others | To consider 1. Approve the Employee Stock Option Plan (ESOP). 2. Acquisition of equity shares of a target company from certain shareholders of the target company. 3. Other business matters. |
| 2025-11-06 | Quarterly Results |
About Beta Drugs
Beta Drugs manufacturing, and marketing of oncology (anti-cancer) products including tablets, capsules, and injections View More- NSE Symbol
- BETA
- BSE Symbol
- 531481
- ISIN
- INE351Y01019
Similar Stocks to Beta Drugs
Popular Stocks
Beta Drugs FAQs
Beta Drugs share price is ₹2,373 As on 08 August, 2026 | 01:45
The Market Cap of Beta Drugs is ₹2463.5 Cr As on 08 August, 2026 | 01:45
The P/E ratio of Beta Drugs is 54 As on 08 August, 2026 | 01:45
The PB ratio of Beta Drugs is 10.1 As on 08 August, 2026 | 01:45
The 52 week High & Low of Beta Drugs is ₹2674/₹990.1 respectively As on 08 August, 2026 | 01:45
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.